Because most of the KRAS mutant CRCs also have APC mutation, we included both in our study cohorts and classify these cases into HES1 (+) and HES1 (−) groups according to the presence or absence of tumor nuclear expression of HES1. This evidence concerns the gene KRAS and neoplasm.